Liver Cancer Patients' Life Expectancy After Interventional Surgery

The life expectancy of liver cancer patients after interventional surgery depends on several factors, including the clinical stage of the cancer, the tumor's response to treatment, the patient's physical condition, and liver function. On average, patients may survive for 2–3 years following interventional treatment, although some may live for more than 5 years, and in rare cases, even achieve a complete cure. However, for those who respond poorly to treatment, life expectancy may be limited to only 0.5–1 year. Therefore, it's important to evaluate each case individually.

Interventional therapy is primarily used for controlling mid-to-late-stage liver cancer, especially when surgical removal is not suitable or when the risk of recurrence is high after surgery. This treatment can help slow tumor growth, reduce tumor size, and maintain stability for a significant period. However, it is generally considered a palliative approach, and in most cases, the cancer may eventually progress after a period of control.

To improve overall survival rates, interventional therapy is often combined with other treatments such as targeted drugs or immunotherapy. If the tumor shrinks significantly, surgical intervention may be reconsidered to potentially extend survival. Following surgical removal, interventional procedures can also be used to prevent recurrence and metastasis. With proper management and no signs of recurrence, patients may achieve long-term survival.